RENEWLIV Price

Overview

Welcome to Dwaey, specifically on RENEWLIV Capsules (Hard Gelatin) page.
This medicine contains an important and useful components, as it consists of Ursodeoxycholic acid.
RENEWLIV is available in the market in concentration 250mg/Capsule and in the form of Capsules (Hard Gelatin).

STRIDES ARCOLAB LIMITED is the producer of RENEWLIV and it is imported from INDIA, The most popular alternatives of RENEWLIV are listed downward .

Mode Of Action

Ursodeoxycholic acid suppresses hepatic synthesis and secretion of cholesterol and also inhibits intestinal absorption of cholesterol.

Indication

• Dissolution of cholesterol-rich gallstones
• Primary biliary cirrhosis
• Prevention of gallstones

Precaution

50% of successfully treated patients will develop further gallstones within 10 yr. Pregnancy and lactation. Monitoring Parameters Monitor LFTs mthly for the 1st 3 mth and every 6 mth thereafter. Lactation: unknown if excreted in breast milk; use caution

Side Effects

• >10% Headache
• Dizziness
• Diarrhea
• Dyspepsia
• Nausea/vomiting
• Back pain
• Upper respiratory tract infection 1-10% Alopecia
• Rash
• Hyperglycemia
• Flatulence
• Peptic ulcer
• Urinary tract infection
• Leukopenia
• Thrombocytopenia
• Cholecystitis >1% Fatigue
• Abdominal pain
• Thrombocytopenia
• Pruritus
• Angioedema
• Peripheral edema
• Biliary pain

Contra indication

Acute inflammation of gallbladder or biliary tract, occlusion of biliary tract, frequent episodes of biliary colic, radio-opaque calcified gallstones, impaired contractility of gallbladder, non-functioning gallbladder, inflammatory bowel disease, hepatic and intestinal conditions interfering w/ enterohepatic recirculation of bile acids, extrahepatic and intrahepatic cholestasis, ileal resection and stoma, regional ileitis, active duodenal and gastric ulcer; acute, chronic or severe hepatic disease.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.